University of Pennsylvania Scheie Eye Institute — Philadelphia, Pennsylvania

University of Pennsylvania Scheie Eye Institute is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Clinical Trials Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Pennsylvania Scheie Eye Institute has participated in 18 clinical trials with 3 currently active.

Therapeutic areas: Retinitis Pigmentosa, Diabetic Retinopathy, Diabetic Macular Edema.

Sponsors: Second Sight Medical Products, Jaeb Center for Health Research, University of Illinois at Chicago.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Philadelphia

Browse all research sites in Pennsylvania · View every site in Philadelphia

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Pennsylvania Scheie Eye Institute?

University of Pennsylvania Scheie Eye Institute has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Pennsylvania Scheie Eye Institute conducted?

University of Pennsylvania Scheie Eye Institute has 18 clinical trials on record, with 3 currently active. Their work covers Retinitis Pigmentosa, Diabetic Retinopathy, Diabetic Macular Edema.

Is University of Pennsylvania Scheie Eye Institute accredited by Crixeo Clinical Trials?

University of Pennsylvania Scheie Eye Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Pennsylvania Scheie Eye Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.